| Vial description: |
CASH, CASP8AP1, CLARP, FLAME-1, MRIT, Usurpin, c-FLIP |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
O15519 |
| Application: |
Western Blot |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
CFLAR / Casper / I-FLICE (206-222) |
| Short name: |
anti-CFLAR / Casper / I-FLICE (206-222) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
member 6) (TNFRSF6)-associated via death domain-like apoptosis regulator / Casper / I-FLICE (206-222) (Antibody to), antibody to-CASP8 and Fas (TNF receptor superfamily |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CFLAR and IDBG-78386 and ENSG00000003402 and 8837, FLIP and IDBG-643202 and ENSBTAG00000010998 and 497199, Plasma membranes, c-FLIP and c-FLIPL and c-FLIPR and c-FLIPS and CASH and CASP8AP1 and Casper and CLARP and FLAME and FLAME-1 and FLAME1 and FLIP and I-FLICE and MRIT, death effector domain binding, this GO :0002020 and protease binding and molecular function this GO :0004197 and cysteine-type endopeptidase activity and molecular function this GO :0005123 and death receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006508 and proteolysis and biological process this GO :0006915 and apoptotic process and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008234 and cysteine-type peptidase activity and molecular function this GO :0014732 and skeletal muscle atrophy and biological process this GO :0014842 and regulation of satellite cell proliferation and biological process this GO :0014866 and skeletal myofibril assembly and biological process this GO :0016032 and viral process and biological process this GO :0031264 and death-inducing signaling complex and cellular component this GO :0031265 and CD95 death-inducing signaling complex and cellular component this GO :0032403 and protein complex binding and molecular function this GO :0035877 and death effector domain binding and molecular function this GO :0042981 and regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043123 and positive regulation of I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043403 and skeletal muscle tissue regeneration and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0051092 and positive regulation of NF-kappaB transcription factor activity and biological process this GO :0060544 and regulation of necroptotic process and biological process this GO :0097190 and apoptotic signaling pathway and biological process this GO :0097342 and ripoptosome and cellular component this GO :1901740 and negative regulation of myoblast fusion and biological process this GO :1902042 and negative regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :2001237 and negative regulation of extrinsic apoptotic signaling pathway and biological process this GO :2001239 and regulation of extrinsic apoptotic signaling pathway in absence of ligand and biological process, this GO :0002020 : protease binding, this GO :0002020 : protease binding and also this GO :0004197 : cysteine-type endopeptidase activity and also this GO :0005123 : death receptor binding and also this GO :0005515 : protein binding and also this GO :0008047 : enzyme activator activity and also this GO :0008234 : cysteine-type peptidase activity and also this GO :0032403 : protein complex binding and also this GO :0035877 : death effector domain binding, this GO :0004197 : cysteine-type endopeptidase activity, this GO :0005123 : death receptor binding, this GO :0005515 : protein binding, this GO :0008047 : enzyme activator activity, this GO :0008234 : cysteine-type peptidase activity, this GO :0032403 : protein complex binding, this GO :0035877 : death effector domain binding, CASP8 and FADD-like apoptosis regulator |
| Identity: |
1876 |
| Gene: |
CFLAR |
More about : CFLAR |
| Long gene name: |
CASP8 and FADD like apoptosis regulator |
| Synonyms gene: |
CASP8AP1 |
| Synonyms gene name: |
CASP8 and FADD-like apoptosis regulator |
| Synonyms: |
CASH Casper CLARP FLAME FLIP I-FLICE MRIT c-FLIP |
| Locus: |
2q33, 1 |
| Discovery year: |
1999-05-07 |
| GenBank acession: |
AF005774 |
| Entrez gene record: |
8837 |
| Pubmed identfication: |
9208847 9217161 |
| RefSeq identity: |
NM_003879 |
| Classification: |
Endogenous ligands Death effector domain containing Death inducing signaling complex |
| Havana BLAST/BLAT: |
OTTHUMG00000132819 |